Double-Blind, Placebo-Controlled Study of Amantadine Hydrochloride in the Treatment of Children With Autistic Disorder

Bryan H. King(University of Pittsburgh), Edwin H. Cook(University of Chicago), Benjamin L. Handen(Kennedy Krieger Institute), Martin J. Lubetsky(University of Pittsburgh), Andrew W. Zimmerman(Kennedy Krieger Institute), STEPHEN R. HOOPER(University of Pittsburgh), Pablo Davanzo(University of Pittsburgh), Elisa S. Shernoff(University of Wisconsin–Madison), Scott M. Myers(University of Pittsburgh), Linmarie Sikich(Duke University), Bennett Leventhal(American Academy of Child and Adolescent Psychiatry), Elisabeth M. Dykens(Vanderbilt University), Catherine Lord(University of California, Los Angeles), Colin T. Dourish(University of Oxford), Jennifer Levitt(Kennedy Krieger Institute), William McMahon(University of Pittsburgh), ERIN CANTWELL(Kennedy Krieger Institute), Bhavik Shah(Kennedy Krieger Institute), D. MARK WRIGHT(Kennedy Krieger Institute), KWANNA WILLIAMSON(University of Pittsburgh), CATHERINE A. JASELSKIS(University of Pittsburgh), MICHAEL SNAPE(University of Pittsburgh), Sally Ozonoff(University of California Davis Medical Center)

Journal of the American Academy of Child & Adolescent Psychiatry

June 1, 2001

Cited by 196

Related Papers

|Molecular Psychiatry|2013|2.8k

|Nature Reviews Disease Primers|2020|1.6k

|Neuron|2015|1.5k

|PEDIATRICS|2011|1.4k

|Neurology|2000|1.1k